Anti-SARS-CoV-2 monoclonal antibodies are mainstay COVID-19 therapeutics. Safety,
antiviral, and clinical efficacy of bamlanivimab were evaluated in the randomized controlled trial …

SARS-CoV-2 mutations that cause resistance to monoclonal antibody (mAb) therapy have
been reported. However, it remains unclear whether in vivo emergence of SARS-CoV-2 …

Non-suppressible HIV-1 viremia (NSV) is defined as persistent low-level viremia on antiretroviral
therapy (ART) without evidence of ART non-adherence or significant drug resistance. …

Background: Although symptom and viral rebound have been reported after nirmatrelvir–ritonavir
treatment, the trajectories of symptoms and viral load during the natural course of …

Despite vaccination and antiviral therapies, immunocompromised individuals are at risk for
prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but the …

Background: Development of safe and effective SARS-CoV-2 therapeutics is a high priority.
Amubarvimab and romlusevimab are noncompeting anti–SARS-CoV-2 monoclonal …

Coastal mangrove forests provide important ecosystem goods and services, including carbon
sequestration, biodiversity conservation, and hazard mitigation. However, they are being …

This paper presents the land cover classification capabilities of fully versus partially polarimetric
SAR data for C- and L-band frequencies. Maximum Likelihood classifier with complex …

Background: There are reports of viral RNA and symptom rebound in people with COVID-19
treated with nirmatrelvir/ritonavir. Since the natural course of viral and symptom trajectories …

To mitigate the loss of lives during the COVID-19 pandemic, emergency use authorization
was given to several anti-SARS-CoV-2 monoclonal antibody (mAb) therapies for the treatment …